Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Clinical trial NCT00479128 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00479128
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-28
- Primary completion
- 2026-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.